Trastuzumab in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Heart Tumor Cells, Cultured Killer Cells, Natural Neoplastic Stem Cells Neoplastic Cells, Circulating MCF-7 Cells Blood-Brain Barrier

Organisms4

Mice, Nude Mice, SCID Rats, Nude Mice, Inbred BALB C

Diseases42

Breast Neoplasms Neoplasm Metastasis Heart Diseases Meningeal Carcinomatosis Carcinoma, Ductal, Breast Central Nervous System Neoplasms Disease Progression Lymphatic Metastasis Carcinoma, Lobular Neoplasm Recurrence, Local Brain Neoplasms Neoplasms Stomach Neoplasms Ventricular Dysfunction, Left Carcinoma Heart Failure Ovarian Neoplasms Adenocarcinoma, Papillary Neoplasms, Hormone-Dependent Bone Neoplasms Drug-Related Side Effects and Adverse Reactions Breast Neoplasms, Male Adenocarcinoma Mammary Neoplasms, Animal Cardiomyopathies Carcinoma, Ductal Inflammatory Breast Neoplasms Esophageal Neoplasms Neoplasm Invasiveness Adenocarcinoma, Clear Cell Carcinoma, Endometrioid Lung Neoplasms Mammary Neoplasms, Experimental Rhabdoid Tumor Neutropenia Recurrence Cystadenocarcinoma, Serous Peritoneal Neoplasms Neoplastic Cells, Circulating Leukopenia Disease Models, Animal Salivary Gland Neoplasms

Chemicals and Drugs87

Antibodies, Monoclonal, Humanized Receptor, erbB-2 Antibodies, Monoclonal Antineoplastic Agents Maytansine Anthracyclines Taxoids Paclitaxel Quinazolines Cardiotoxins Epirubicin Cyclophosphamide Vinblastine Receptor, erbB-3 Lead Radioisotopes Actinium Immunoglobulin Subunits Deoxycytidine PTEN Phosphohydrolase Doxorubicin Indium Radioisotopes Fluorouracil Receptor, Epidermal Growth Factor Astatine Receptors, Estrogen Tumor Markers, Biological Proto-Oncogene Proteins c-akt Bridged Compounds Protein Kinase Inhibitors Lactams, Macrocyclic Receptors, Progesterone Phosphatidylinositol 3-Kinases Antigens, CD24 Benzoquinones Carboplatin Iodobenzoates Immunoconjugates Aromatase Inhibitors Biomarkers, Pharmacological Heterocyclic Compounds, 1-Ring Neuregulin-1 Nitriles Pentetic Acid Antineoplastic Agents, Hormonal Dopamine and cAMP-Regulated Phosphoprotein 32 HSP90 Heat-Shock Proteins Nanoconjugates Receptor, IGF Type 1 Quinazolinones Mucin-4 Epothilones Phenylmercuric Acetate Tamoxifen Triazoles Antineoplastic Agents, Phytogenic Receptors, IgG Cyclin-Dependent Kinase Inhibitor p27 Antibodies, Bispecific RNA, Small Interfering Floxuridine Tetrazolium Salts Quinolines Streptavidin Coloring Agents Immunotoxins Radiopharmaceuticals Phosphatidylinositol 3-Kinase Ribonucleosides Antibiotics, Antineoplastic Angiogenesis Inhibitors 3-Phosphoinositide-Dependent Protein Kinases Single-Chain Antibodies Antibodies, Neoplasm Antimetabolites, Antineoplastic Antigens, Neoplasm Protein-Serine-Threonine Kinases Sirolimus Chemokine CXCL9 Cyclin-Dependent Kinase 6 Tetracyclines rhoB GTP-Binding Protein Growth Differentiation Factor 15 Isotretinoin Cisplatin Epitopes Phosphothreonine Presenilin-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Treatment Outcome In Situ Hybridization, Fluorescence Disease-Free Survival Neoadjuvant Therapy Xenograft Model Antitumor Assays Fractionation, Field Flow Drug Administration Schedule Molecular Targeted Therapy Immunohistochemistry Neoplasm Staging Animal Use Alternatives Kaplan-Meier Estimate Prognosis Survival Analysis Clinical Trials as Topic Survival Rate Tumor Burden Infusions, Intravenous Flow Cytometry Radioimmunotherapy Clinical Trials, Phase III as Topic Neoplasm Transplantation Retrospective Studies Clinical Trials, Phase II as Topic Drug Delivery Systems Quality-Adjusted Life Years Combined Modality Therapy Randomized Controlled Trials as Topic Transplantation, Heterologous Blotting, Western Drug Screening Assays, Antitumor Nanoconjugates Maximum Tolerated Dose Mastectomy Isotope Labeling Stroke Volume Proportional Hazards Models Immunoenzyme Techniques Markov Chains Cohort Studies Protein Engineering Multicenter Studies as Topic Positron-Emission Tomography Enzyme-Linked Immunosorbent Assay Prospective Studies Pilot Projects Follow-Up Studies Chemistry Techniques, Analytical Chemoradiotherapy, Adjuvant Feasibility Studies Mammary Neoplasms, Experimental Drug Evaluation, Preclinical Multimodal Imaging Risk Assessment Mastectomy, Segmental Reverse Transcriptase Polymerase Chain Reaction Immunoblotting Multivariate Analysis Patient Selection Immunotherapy Gene Expression Profiling In Situ Hybridization Predictive Value of Tests Sensitivity and Specificity Remission Induction Paraffin Embedding Treatment Failure Disease Models, Animal Sonication Models, Biological Risk Factors Immunotherapy, Adoptive

Phenomena and Processes33

Genes, erbB-2 Drug Resistance, Neoplasm Antibody-Dependent Cell Cytotoxicity Gene Amplification Drug Synergism Gene Expression Regulation, Neoplastic Cell Proliferation Signal Transduction Genes, erbB Alpha Particles Dose-Response Relationship, Drug Phosphorylation Apoptosis Cell Growth Processes Maximum Tolerated Dose Tissue Distribution Time Factors Receptor Cross-Talk Stroke Volume Down-Regulation Cell Survival Markov Chains Up-Regulation Ventricular Function, Left Cell Cycle Protein Binding G1 Phase Cell Cycle Checkpoints Drug Antagonism G1 Phase Sensitivity and Specificity Enzyme Activation Drug Interactions Dimerization

Disciplines and Occupations4

Immunohistochemistry Pharmacoepidemiology Medical Oncology Pathology, Clinical

Technology, Industry, Agriculture1

Information Science3

Survival Rate Quality-Adjusted Life Years Newspapers

Health Care33

Treatment Outcome Disease-Free Survival Kaplan-Meier Estimate Survival Analysis Clinical Trials as Topic Survival Rate Clinical Trials, Phase III as Topic Retrospective Studies Clinical Trials, Phase II as Topic Intention to Treat Analysis Quality-Adjusted Life Years Drug Costs Cost-Benefit Analysis Randomized Controlled Trials as Topic International Agencies Proportional Hazards Models Markov Chains Cohort Studies Multicenter Studies as Topic Prospective Studies Pilot Projects Safety Follow-Up Studies Feasibility Studies Risk Assessment Cost Savings Multivariate Analysis Patient Selection Predictive Value of Tests Sensitivity and Specificity Treatment Failure Technology Assessment, Biomedical Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antibodies, Monoclonal, Humanized Receptor, erbB-2 Antibodies, Monoclonal Breast Neoplasms Antineoplastic Agents Genes, erbB-2 Maytansine Antineoplastic Combined Chemotherapy Protocols Drug Resistance, Neoplasm Anthracyclines Taxoids Cell Line, Tumor Paclitaxel Chemotherapy, Adjuvant Quinazolines Neoplasm Metastasis Treatment Outcome In Situ Hybridization, Fluorescence Antibody-Dependent Cell Cytotoxicity Disease-Free Survival Neoadjuvant Therapy Xenograft Model Antitumor Assays Cardiotoxins Gene Amplification Epirubicin Mice, Nude Cyclophosphamide Vinblastine Drug Synergism Receptor, erbB-3 Fractionation, Field Flow Lead Radioisotopes Actinium Immunoglobulin Subunits Deoxycytidine PTEN Phosphohydrolase Drug Administration Schedule Molecular Targeted Therapy Gene Expression Regulation, Neoplastic Heart Diseases Doxorubicin Immunohistochemistry Indium Radioisotopes Neoplasm Staging Fluorouracil Animal Use Alternatives Kaplan-Meier Estimate Receptor, Epidermal Growth Factor Astatine Meningeal Carcinomatosis Carcinoma, Ductal, Breast Central Nervous System Neoplasms Prognosis Survival Analysis Disease Progression Receptors, Estrogen Tumor Markers, Biological Cell Proliferation Signal Transduction Genes, erbB Proto-Oncogene Proteins c-akt Clinical Trials as Topic Alpha Particles Mice, SCID Dose-Response Relationship, Drug Bridged Compounds Survival Rate Tumor Burden Protein Kinase Inhibitors Lymphatic Metastasis Lactams, Macrocyclic Receptors, Progesterone Phosphatidylinositol 3-Kinases Infusions, Intravenous Antigens, CD24 Benzoquinones Flow Cytometry Carboplatin Radioimmunotherapy Clinical Trials, Phase III as Topic Neoplasm Transplantation Retrospective Studies Iodobenzoates Carcinoma, Lobular Immunoconjugates Clinical Trials, Phase II as Topic Neoplasm Recurrence, Local Intention to Treat Analysis Aromatase Inhibitors Drug Delivery Systems Quality-Adjusted Life Years Brain Neoplasms Biomarkers, Pharmacological Neoplasms Drug Costs Heterocyclic Compounds, 1-Ring Combined Modality Therapy Neuregulin-1 Cost-Benefit Analysis Phosphorylation

No FAQ available that match "trastuzumab in patients"